Bank of America’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
|
|||||
|
2025
Q1 | $226K | Sell |
|
|||||
|
2024
Q4 | $1.54M | Sell |
|
|||||
|
2024
Q3 | $4.42M | Hold |
|
|||||
|
2024
Q2 | $4.53M | Sell |
|
|||||
|
2024
Q1 | $7.38M | Sell |
|
|||||
|
2023
Q4 | $3.73M | Buy |
|
|||||
|
2023
Q3 | $3.66M | Sell |
|
|||||
|
2023
Q2 | $4.35M | Sell |
|
|||||
|
2023
Q1 | $5.89M | Buy |
|
|||||
|
2022
Q4 | $6.92M | Buy |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | $1.69M | Buy |
|
|||||
|
2022
Q1 | $1.08M | Sell |
|
|||||
|
2021
Q4 | $2.02M | Sell |
|
|||||
|
2021
Q3 | $3.79M | Buy |
|
|||||
|
2021
Q2 | $55K | Sell |
|
|||||
|
2021
Q1 | $1.89M | Buy |
|
|||||
|
2020
Q4 | $13K | Buy |
|
|||||
|
2020
Q3 | $13K | Sell |
|
|||||
|
2020
Q2 | $22K | Sell |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $6K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $26K | Buy |
|
|||||
|
2019
Q1 | $1K | Sell |
|
|||||
|
2018
Q4 | $6K | Buy |
|
|||||
|
2018
Q3 | $6K | Sell |
|
|||||
|
2018
Q2 | $46K | Sell |
|
|||||
|
2018
Q1 | $66K | Sell |
|
|||||
|
2017
Q4 | $85K | Buy |
|
|||||
|
2017
Q3 | $6K | Buy |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $131K | Buy |
|
|||||
|
2016
Q1 | $3K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4K | Buy |
|